| Shokeir, Ahmed A |
| Recruiting | N/A | 50 | RoW | Low Energy Shock Wave Treatment, Sham Treatment | Mansoura University | Non-Muscle Invasive Bladder Cancer | 11/22 | 11/23 | | |
NCT04664816: Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer |
|
|
| Recruiting | N/A | 110 | RoW | n-3PUFAs Treatment, Treatment, Placebo Treatment, Control | Mansoura University | Non-Muscle Invasive Bladder Cancer | 12/22 | 12/23 | | |
| Mosbah, Ahmed E |
NCT04939194: Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. |
|
|
| Enrolling by invitation | 3 | 200 | RoW | Fast Track Protocol | Mansoura University | Bladder Cancer | 01/23 | 07/23 | | |
| Recruiting | N/A | 50 | RoW | Low Energy Shock Wave Treatment, Sham Treatment | Mansoura University | Non-Muscle Invasive Bladder Cancer | 11/22 | 11/23 | | |
NCT04167631: Can VI-RADS/ADC Accurately Stage Bladder Cancer?? |
|
|
| Active, not recruiting | N/A | 150 | RoW | Multi-parametric MRI, MP-MRI | Mansoura University | MRI Contrast Media Adverse Reaction, Bladder Cancer, Bladder Disease, Bladder Neoplasm, Bladder Urothelial Carcinoma, Bladder Cancer Stage, Diagnoses Disease | 12/24 | 12/24 | | |
NCT05969964: Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins |
|
|
| Recruiting | N/A | 370 | RoW | Avoid second resection after initial complete resection | Mansoura University | Bladder Cancer Stage I | 08/25 | 12/25 | | |
| Osman, Yasser M |
NCT05273671: Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics |
|
|
| Recruiting | 4 | 126 | RoW | Nalbuphine, nalophen, Dexmedetomidine, Precedex, normal Saline, saline | Alexandria University | Agitation | 06/22 | 06/22 | | |
NCT04566796: Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates |
|
|
| Recruiting | N/A | 60 | RoW | Sugammadex, Neostigmine | Alexandria University | Sugammadex | 02/21 | 02/21 | | |
NCT05343234: Drug Name Identification an Ignored Patient's Problem That Needs a Solution |
|
|
| Recruiting | N/A | 500 | RoW | Placebo, placebo drugs | Alexandria University | Remember the Name of a Given Drug | 06/22 | 06/22 | | |
| Abol-Enein, Hassan |
NCT04664816: Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer |
|
|
| Recruiting | N/A | 110 | RoW | n-3PUFAs Treatment, Treatment, Placebo Treatment, Control | Mansoura University | Non-Muscle Invasive Bladder Cancer | 12/22 | 12/23 | | |
| Elsawy, Amr A |
NCT04325880: Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms |
|
|
| Recruiting | 3 | 240 | RoW | Mirabegron 50 MG, Tamsulosin, Solifenacin Succinate 10 MG, Placebo oral tablet | Mansoura University | Ureteral Stent, Stent Related Symptoms | 06/22 | 07/22 | | |
NCT05384197: Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients |
|
|
| Recruiting | 3 | 280 | RoW | Enhanced regimen, Extended regimen | Mansoura University | Renal Stone | 05/23 | 07/23 | | |
NCT05146635: Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial |
|
|
| Recruiting | N/A | 110 | RoW | Intravesical Bcg, Intravesical chemotherapy (epirubicin) | Mansoura University | Bladder Cancer | 12/22 | 01/23 | | |
NCT05167916: Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy? |
|
|
| Recruiting | N/A | 200 | RoW | Outpatient check cytoscopy, Urine cytology | Mansoura University | Bladder Cancer | 12/22 | 01/23 | | |
NCT05146674: Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms |
|
|
| Not yet recruiting | N/A | 80 | RoW | Tadalafil 5mg | Mansoura University | Lower Urinary Tract Symptoms | 12/22 | 01/23 | | |
NCT05460559: Endoscopic Combined Intrarenal Surgery Versus Multi-Tract Percutaneous Nephrolithotomy for Complex Renal Stones: |
|
|
| Recruiting | N/A | 110 | RoW | Group A (p-PCNL) procedure, Group B (s-ECIRS) procedure | Mansoura University | Stone, Kidney | 12/23 | 01/24 | | |
NCT04643145: Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial |
|
|
| Active, not recruiting | N/A | 130 | RoW | Flexible ureteroscopy for renal calculi less than 20 mm | Mansoura University | Stones, Kidney | 12/24 | 12/24 | | |
| Wadie, Bassem |
NCT05490082: Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation |
|
|
| Recruiting | 3 | 100 | RoW | Mirabegron, Propevirine, Solifenacin | Mansoura University | Voiding Disorders | 03/23 | 10/23 | | |
| Elbaz, Ramy |
| Not yet recruiting | N/A | 160 | RoW | Mini PCNL (mini percutaneous nephrolithotomy), RIRS (retrograde intrarenal surgery/ flexible URS) | Mansoura University | Urolithiasis | 03/25 | 04/25 | | |
